Mission Statement, Vision, & Core Values of Elanco Animal Health Incorporated (ELAN)

How well do you know the driving forces behind Elanco Animal Health Incorporated (ELAN)? With a strong finish to 2024, achieving its sixth consecutive quarter of organic constant currency revenue growth, the company's mission, vision, and core values play a crucial role in its performance. But what exactly are they, and how do they translate into Elanco's strategic and operational decisions?

Understanding these guiding principles is key to grasping the company's direction and priorities. Did you know that Elanco's revenue for 2024 reached $4.439 billion, a 0.5% increase from 2023? Dive in to explore how the mission, vision, and core values align with such financial outcomes and strategic initiatives.

Elanco Animal Health Incorporated (ELAN) An Overview of

Elanco Animal Health Incorporated, publicly traded as (ELAN), has a rich history rooted in animal care and health solutions. Originally part of Eli Lilly and Company, Elanco became an independent company in 2019. The company develops and markets products for companion and food animals, with a focus on improving animal health and welfare. Elanco operates on a global scale, offering a diverse portfolio of products including vaccines, parasiticides, antimicrobials, and nutritional health products. These products support various aspects of animal health, from preventing diseases to enhancing overall well-being.

As of April 2025, Elanco continues to serve the animal health sector. Elanco's portfolio includes well-known products and solutions aimed at preventing and treating diseases in pets and livestock. These products range from parasiticides and vaccines to antibiotics and nutritional supplements. Elanco has presence in various markets globally, including North America, Europe, and Asia-Pacific.

Elanco's financial performance demonstrates its position in the animal health industry. In the 2024 fiscal year, Elanco reported a revenue of $4.509 billion. The company's strategic focus on key animal health segments and geographical regions has supported revenue growth. Elanco has been actively managing its debt and financial obligations, as evidenced by its efforts to reduce its leverage ratio. The company's financial strategy includes a focus on margin expansion and efficient capital allocation to drive long-term value.

Elanco's recent financial highlights include:

• Revenue: $4.509 billion for the full year 2024.
• Net Income: Reported net income of $21.5 million, or $0.04 per share on a reported basis, for the full year 2024.
• Adjusted Gross Margin: 60.1% for the full year 2024.
• Strategic Priorities: Focused on portfolio optimization, margin improvement, and deleveraging.

Elanco stands as a key player in the animal health industry, committed to innovation and strategic growth. Want to understand more about Elanco's financial health and stability? Dive deeper into our analysis: Breaking Down Elanco Animal Health Incorporated (ELAN) Financial Health: Key Insights for Investors.

Elanco Animal Health Incorporated (ELAN) Mission Statement

Elanco Animal Health Incorporated (ELAN) is a global animal health company dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, Elanco is committed to helping its customers improve the health of animals in their care, while also making a meaningful impact on local and global communities. Elanco is driven by its vision of Food and Companionship Enriching Life and its Elanco Healthy Purpose™ Sustainability Initiatives – all to advance the health of animals, people, the planet and enterprise.

Elanco's promise is to rigorously innovate to benefit customers and improve the health of animals. For customers, Elanco promises to be their advocate and continually earn their trust, improving the health of animals, and creating value through innovative products, expertise, and service. Elanco finds ways to add value with every customer engagement, addressing what matters most, and constantly raising the bar.

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. At Elanco, they’re driven by their vision of food and companionship enriching life - all to advance the health of animals, people, and the planet.

Elanco's Financial Performance:

• In the third quarter of 2024, Elanco reported revenue of $1,030 million, with organic constant currency growth of 1%.
• The company's full-year 2024 financial guidance includes revenue of $4,420 to $4,450 million, with organic constant currency growth of 3%.
• Elanco exceeded its innovation revenue target for 2024, reaching $461 million.
• For the full year 2024, Elanco reported revenue of $4,439 million, which remained flat compared to the previous year but showed a 3% increase on an organic constant currency basis.
• The company's reported net income for 2024 was $338 million, with an adjusted net income of $452 million.

Elanco's Vision:

Elanco is driven by its vision of Food and Companionship Enriching Life, aiming to advance the health of animals, people, and the planet. Healthy animals are central to addressing global issues that impact physical, mental, and environmental health. Elanco believes that animals are key to solving some of the world's most pressing issues, including meeting the growing demand for protein and quality nutrition, healthcare, and environmental sustainability.

Elanco's Core Values:

Elanco's culture is built on a foundation of core values that guide decisions and behaviors. These values are:

• Integrity: Doing the right thing the right way in every situation.
• Respect: Showing consideration for people, customers, and the animals in their care.
• Excellence: Being accountable, delivering with discipline, and striving for continuous improvement.

These values are reflected in Elanco's commitment to ethical conduct, diversity, and inclusion. The Elanco Code of Conduct highlights these core values, outlining ethical principles and expectations for employees. Elanco's Human Rights Policy reinforces these values, emphasizing the importance of upholding and advancing internationally-recognized human rights across global operations and supply chains.

Elanco's Behavioral Pillars:

Elanco commits to pursuing four behavioral pillars each and every day:

• Involve: Act as One Elanco, asking for opinions rather than telling.
• Deliver: Everything we do is delivered with disciplined execution.
• Own: We are accountable, empowered, and always go the extra mile.
• Innovate: We always challenge for a better, simpler way that drives continuous improvement.

Elanco's Sustainability Initiatives:

Elanco is dedicated to advancing its four intertwined Healthy Purpose™ Pillars: Healthier Animals, Healthier People, Healthier Planet, and Healthier Enterprise. The company's 2023 Environmental, Social and Governance (ESG) Report showcases its dedication to these pillars, highlighting initiatives and partnerships that demonstrate how healthier animals can positively impact major global issues like food security, mental health, social isolation, and environmental sustainability. In 2023, Elanco became a participant in the U.N. Global Compact, furthering its commitment to fundamental business principles involving human rights, labor, anti-corruption, and the environment.

Additional Resources

For more insights into Elanco's investor profile, consider reading: Exploring Elanco Animal Health Incorporated (ELAN) Investor Profile: Who’s Buying and Why?

Elanco Animal Health Incorporated (ELAN) Vision Statement

A vision statement outlines a company's aspirations for the future. While publicly available information on Elanco's specific vision statement is limited as of April 2025, we can infer their strategic direction from their mission, values, and recent initiatives. These elements provide insights into what Elanco aims to achieve in the animal health industry.

Elanco's financial performance and strategic moves reflect its vision. In the fiscal year 2024, Elanco reported revenue of $4.5 billion, demonstrating its significant market presence. Their focus on innovation and strategic acquisitions, like the $7.6 billion acquisition of Bayer Animal Health in 2020, signals a vision of expanding their portfolio and global reach. These actions align with a forward-looking approach to address the evolving needs of animal health.

Here are key aspects of Elanco's implied vision:

• Innovation and Portfolio Expansion: Elanco focuses on developing new animal health solutions and expanding its product offerings through strategic acquisitions.
• Global Leadership: The company aims to strengthen its position as a global leader in the animal health industry.
• Sustainability: Elanco is increasingly focused on sustainable practices and responsible animal care.

Commitment to Innovation

Elanco's commitment to innovation is evident through its investments in research and development. In 2024, the company allocated $425 million to R&D, focusing on novel therapies and diagnostic tools. This investment underscores their vision of pioneering advancements in animal health, addressing unmet needs, and improving animal welfare. Their innovation pipeline includes products targeting various animal species and health conditions, reflecting a broad and ambitious scope.

Global Expansion and Market Leadership

A core element of Elanco's vision is to solidify its global footprint and market leadership. The acquisition of Bayer Animal Health for $7.6 billion in 2020 significantly expanded Elanco's international presence and product portfolio. As of 2024, Elanco operates in over 90 countries, with a strong presence in key markets such as the United States, Europe, and Asia. Their strategic focus on emerging markets indicates a vision of capturing growth opportunities worldwide.

Sustainability and Responsible Animal Care

Elanco is increasingly integrating sustainability into its vision. This includes developing products and practices that promote responsible animal care and reduce the environmental impact of animal agriculture. For example, Elanco has invested in developing feed additives that reduce methane emissions from livestock. These efforts align with a broader vision of promoting animal health while contributing to a more sustainable and responsible food system. Elanco's sustainability initiatives reflect a long-term commitment to environmental stewardship and ethical business practices.

Elanco Animal Health Incorporated (ELAN) Core Values of

While specific details on Elanco's mission statement, vision, and core values as of April 2025 are not available, we can infer key aspects based on their publicly stated goals, initiatives, and financial performance. Elanco's focus appears to be on animal health, sustainability, and creating value for shareholders.

Here's an overview of what those core values likely encompass, supported by available information:

Customer Focus:

Elanco likely places a high value on understanding and meeting the needs of its customers – veterinarians, farmers, and pet owners. This is evident in their wide range of products and services designed to improve animal health and well-being.

• Elanco provides a diverse portfolio of animal health products, including parasiticides, vaccines, and nutritional health products, demonstrating a commitment to addressing various customer needs.
• They are focused on innovation as a key driver. In the Q4 2024 earnings call, Elanco highlighted pipeline progress, including regulatory submissions and approvals, which underscores their dedication to providing new solutions for their customers.

Innovation:

A commitment to innovation is crucial in the animal health industry. Elanco likely prioritizes research and development to create new and improved products and solutions.

• Elanco has invested $469 million in research and development in 2024, reflecting their focus on developing new animal health solutions.
• They have a robust pipeline of new products, including several that have recently received regulatory approval.

Integrity:

Operating with the highest ethical standards is vital for any company, especially in healthcare. Elanco likely emphasizes integrity in all its dealings.

• Elanco is committed to operating in a responsible and sustainable manner.
• They adhere to a code of conduct that emphasizes ethical behavior and compliance with all applicable laws and regulations.

Sustainability:

Increasingly, companies are recognizing the importance of environmental and social responsibility. Elanco likely incorporates sustainability into its core values.

• Elanco has set specific sustainability goals, including reducing its environmental footprint and improving animal welfare.
• In their 2024 ESG report, Elanco highlights their progress in key areas such as responsible sourcing, greenhouse gas emissions, and diversity and inclusion.

Shareholder Value:

As a publicly traded company, Elanco is responsible for creating value for its shareholders. This likely translates into a core value of financial performance and growth.

• Elanco reported revenue of $4.509 billion for the fiscal year 2024.
• Elanco is focused on driving profitable growth and improving its financial performance.

For more insights into Elanco and its investors, check out: Exploring Elanco Animal Health Incorporated (ELAN) Investor Profile: Who’s Buying and Why?